
Overview
Imad Al-Azem is a Rheumatologist practicing medicine in Dearborn, Michigan.
Dr. Al-Azem is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Osteoporosis, Postmenopausal Osteoporosis, Liver Embolization, and Pacemaker Implantation.
Dr. Al-Azem is board certified in American Board Of Internal Medicine. Dr. Al-Azem is currently accepting new patients.
Graduate Institution
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
4700 Greenfield Road, Dearborn, MI 48126
Taubman Center
Dr. J. Michelle Kahlenberg MD, PhD is a physician scientist and Associate Professor of Internal Medicine at the University of Michigan. She completed her MD, PhD, and Internal Medicine training at Case Western Reserve University and completed her fellowship in Rheumatology at the University of Michigan. She joined the University of Michigan faculty in 2011, was appointed Assistant Professor in 2012, and was promoted to Associate Professor with tenure in 2018. She has been running her own laboratory and has been an active member of the Immunology Training Program since 2013. Her clinical work is centered on the care of complicated lupus patients, including those with refractory skin disease. Her R01-funded research laboratory combines translational approaches using patient samples and murine models to uncover the mechanisms that drive lupus and lupus flares. In particular, she is focused on unraveling the pathogenic mechanisms in cutaneous lupus, the factors that drive photosensitivity, and how skin inflammation can influence systemic lupus activity. Her work has received institutional accolades and national recognition from the Arthritis National Research Foundation, The Rheumatology Research Foundation, American Society for Clinical Investigation and the Lupus Foundation of America. In her spare time, she enjoys organic gardening, working on the family farm EMMA Acres run by her husband, Mark, and spending time with her husband and children. Dr. Kahlenberg is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus (SLE), Dermatomyositis, and Mevalonate Kinase Deficiency. Dr. Kahlenberg is board certified in Rheumatology. Dr. Kahlenberg is currently accepting new patients.
Taubman Center
Dr. Fox is a graduate of the Massachusetts Institute of Technology and Harvard Medical School. Following internal medicine residency and rheumatology fellowship at the Brigham and Women's Hospital, he joined the faculty of the University of Michigan School of Medicine in 1985. Dr. Fox is Professor of Internal Medicine and, from 1990 to 2018, was Chief of the Division of Rheumatology. In addition, he co-directs the University of Michigan Clinical Autoimmunity Center of Excellence. In 2013, Dr. Fox became the Frederick G. L. Huetwell and William D. Robinson, M.D. Professor of Rheumatology. Dr. Foxs research focuses on defining and characterizing pathways of human T cell activation, determining the role of these pathways in the pathogenesis of autoimmune disease, investigating T cell interactions with synovial fibroblasts, understanding the role of interleukin-17 in arthritis, and exploring novel approaches to the treatment of rheumatoid arthritis and scleroderma. He is author of more than 230 scientific papers and book chapters and has served on the Editorial Board of Arthritis & Rheumatism, as an Associate Editor and Section Editor of the Journal of Immunology and as an Associate Editor of the Journal of Clinical Investigation. His published work has been cited more than 10,000 times. He is a member of the American Society for Clinical Investigation and the Association of American Physicians. Dr. Fox is also active in the clinical care of patients with rheumatic diseases and in teaching students and fellows in both clinical and research settings. Dr. Fox has been an ACR ()American College of Rheumatology) member since 1985, an ACR volunteer since 1991, and an ACR Master since 2018. He has been a member of 12 ACR and RRF committees and task forces and chaired the Publications Committee, Finance Committee, and Monitoring Committee. In 2011-2012, Dr. Fox later co-chaired the ACR Task Force on Academic Rheumatology. From 2007-2008, Dr. Fox served as the seventy-first President of the American College of Rheumatology and the sixth ACR President from the University of Michigan. Dr. Fox currently holds leadership positions in the Immune Tolerance Network and in the Biomarkers Consortium of the Foundation for the NIH. Dr. Fox is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Scleroderma, Systemic Sclerosis (SSc), Adult Still's Disease, and Tissue Biopsy. Dr. Fox is currently accepting new patients.
Taubman Center
John Varga is a Rheumatologist practicing medicine in Ann Arbor, Michigan. Dr. Varga is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Localized Scleroderma. Dr. Varga is board certified in Rheumatology and Internal Medicine. Dr. Varga is currently accepting new patients.
Frequently Asked Questions about Dr. Imad A. Al-Azem
How do I make an appointment with Dr. Imad A. Al-Azem?
You can book an appointment with Dr. Imad A. Al-Azem by calling their office at 313-945-6100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Imad A. Al-Azem a top-rated expert for Rheumatoid Arthritis (RA)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Imad A. Al-Azem is classified as an Advanced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Imad A. Al-Azem specialize in?
While Dr. Imad A. Al-Azem is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Osteoporosis, and Postmenopausal Osteoporosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.
Does Dr. Imad A. Al-Azem accept my insurance?
Dr. Imad A. Al-Azem accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 313-945-6100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Felty SyndromeDr. Al-Azem isAdvanced. Learn about Felty Syndrome.
- FibromyalgiaDr. Al-Azem isAdvanced. Learn about Fibromyalgia.
- GoutDr. Al-Azem isAdvanced. Learn about Gout.
- OsteoporosisDr. Al-Azem isAdvanced. Learn about Osteoporosis.
- Postmenopausal OsteoporosisDr. Al-Azem isAdvanced. Learn about Postmenopausal Osteoporosis.
- PsoriasisDr. Al-Azem isAdvanced. Learn about Psoriasis.
- Psoriatic ArthritisDr. Al-Azem isAdvanced. Learn about Psoriatic Arthritis.
- Raynaud PhenomenonDr. Al-Azem isAdvanced. Learn about Raynaud Phenomenon.
- Rheumatoid Arthritis (RA)Dr. Al-Azem isAdvanced. Learn about Rheumatoid Arthritis (RA).
- Vitamin D DeficiencyDr. Al-Azem isAdvanced. Learn about Vitamin D Deficiency.
- Experienced
- Ankylosing SpondylitisDr. Al-Azem isExperienced. Learn about Ankylosing Spondylitis.
- ArthritisDr. Al-Azem isExperienced. Learn about Arthritis.
- Axial Spondyloarthritis (AxSpA)Dr. Al-Azem isExperienced. Learn about Axial Spondyloarthritis (AxSpA).
- Behcet DiseaseDr. Al-Azem isExperienced. Learn about Behcet Disease.
- BoilsDr. Al-Azem isExperienced. Learn about Boils.
- BursitisDr. Al-Azem isExperienced. Learn about Bursitis.
- CarbuncleDr. Al-Azem isExperienced. Learn about Carbuncle.
- Cutaneous Lupus Erythematosus (CLE)Dr. Al-Azem isExperienced. Learn about Cutaneous Lupus Erythematosus (CLE).
- Discoid Lupus Erythematosus (DLE)Dr. Al-Azem isExperienced. Learn about Discoid Lupus Erythematosus (DLE).
- FolliculitisDr. Al-Azem isExperienced. Learn about Folliculitis.
- GastrostomyDr. Al-Azem isExperienced. Learn about Gastrostomy.
- Interstitial KeratitisDr. Al-Azem isExperienced. Learn about Interstitial Keratitis.
- Intestinal CancerDr. Al-Azem isExperienced. Learn about Intestinal Cancer.
- Liver EmbolizationDr. Al-Azem isExperienced. Learn about Liver Embolization.
- Lung NodulesDr. Al-Azem isExperienced. Learn about Lung Nodules.
- MASS PhenotypeDr. Al-Azem isExperienced. Learn about MASS Phenotype.
- MelorheostosisDr. Al-Azem isExperienced. Learn about Melorheostosis.
- Melorheostosis with OsteopoikilosisDr. Al-Azem isExperienced. Learn about Melorheostosis with Osteopoikilosis.
- Mevalonate Kinase DeficiencyDr. Al-Azem isExperienced. Learn about Mevalonate Kinase Deficiency.
- Mixed Connective Tissue DiseaseDr. Al-Azem isExperienced. Learn about Mixed Connective Tissue Disease.
- Multifocal FibrosclerosisDr. Al-Azem isExperienced. Learn about Multifocal Fibrosclerosis.
- NeuroretinitisDr. Al-Azem isExperienced. Learn about Neuroretinitis.
- NeurosarcoidosisDr. Al-Azem isExperienced. Learn about Neurosarcoidosis.
- OsteopeniaDr. Al-Azem isExperienced. Learn about Osteopenia.
- Pacemaker ImplantationDr. Al-Azem isExperienced. Learn about Pacemaker Implantation.
- Plaque PsoriasisDr. Al-Azem isExperienced. Learn about Plaque Psoriasis.
- Polymyalgia RheumaticaDr. Al-Azem isExperienced. Learn about Polymyalgia Rheumatica.
- PolymyositisDr. Al-Azem isExperienced. Learn about Polymyositis.
- Rheumatoid Lung DiseaseDr. Al-Azem isExperienced. Learn about Rheumatoid Lung Disease.
- Rheumatoid PneumoconiosisDr. Al-Azem isExperienced. Learn about Rheumatoid Pneumoconiosis.
- Rheumatoid VasculitisDr. Al-Azem isExperienced. Learn about Rheumatoid Vasculitis.
- Rhizomelic PseudopolyarthritisDr. Al-Azem isExperienced. Learn about Rhizomelic Pseudopolyarthritis.
- SarcoidosisDr. Al-Azem isExperienced. Learn about Sarcoidosis.
- ScleromaDr. Al-Azem isExperienced. Learn about Scleroma.
- Sjogren SyndromeDr. Al-Azem isExperienced. Learn about Sjogren Syndrome.
- Spontaneous Coronary Artery Dissection (SCAD)
- Systemic Lupus Erythematosus (SLE)Dr. Al-Azem isExperienced. Learn about Systemic Lupus Erythematosus (SLE).
- Systemic Sclerosis (SSc)Dr. Al-Azem isExperienced. Learn about Systemic Sclerosis (SSc).
- TenosynovitisDr. Al-Azem isExperienced. Learn about Tenosynovitis.
- Undifferentiated Connective Tissue Disease (UCTD)
- VasculitisDr. Al-Azem isExperienced. Learn about Vasculitis.


